Delivery Order SPE2DB20D2001-SPE2DB26FPLHC
- Not listed
- The Defense Logistics Agency awarded a $1,904.63 firm fixed price delivery order to AmerisourceBergen Drug Corp on September 4, 2025, for the supply of Mounjaro 5 mg/0.5 mL pens (0.5 mL). This competitively awarded, non-set-aside contract is scheduled for completion by September 5, 2025, with performance occurring at AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. The delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop...
- The Defense Logistics Agency awarded a delivery order valued at $2,833.74 to AmerisourceBergen Drug Corp for the supply of Mounjaro 7.5 mg/0.5 mL pen (0.5 mL), a diabetes medication. The contract, awarded on September 10, 2025, with an ultimate completion date of September 11, 2025, represents a firm fixed price delivery order with no set-aside designation. Performance will take place at AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. This delivery order is issued under...
- The Defense Logistics Agency awarded a $17,003.05 firm fixed price delivery order to AmerisourceBergen Drug Corp on September 18, 2025, for the supply of Mounjaro 7.5 mg/0.5 mL pens. This non-set-aside competitive award, with an ultimate completion date of September 19, 2025, will be performed at the contractor's Conshohocken, Pennsylvania location. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and critical federal medical procurement vendor, fulfills this delivery order...
- The Defense Logistics Agency awarded a $5,034.46 firm fixed price delivery order to AmerisourceBergen Drug Corp on September 3, 2025, for the supply of Mounjaro 7.5 mg/0.5 mL pens (0.5 mL). This non-set-aside competitive award is scheduled for completion by September 4, 2025, with performance occurring at AmerisourceBergen's facility in Conshohocken, Pennsylvania. The delivery order is issued under AmerisourceBergen's Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX),...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 31, 2025, for the supply of Mounjaro 7.5 mg/0.5 mL pens valued at $2,614.05. This is a firm fixed-price delivery order with an ultimate completion date of August 1, 2025, and represents a non-set-aside competitive award. The place of performance is listed as AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger Indefinite...
- The Defense Logistics Agency (DLA) awarded AmerisourceBergen Drug Corp a $3,228.25 delivery order on August 29, 2025, for the supply of Mounjaro 7.5 mg/0.5 ml pens with a completion date of September 2, 2025. This is a firm fixed price delivery order with no set-aside designation, meaning the award was competitively issued. The place of performance is listed as AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's...
- The Defense Logistics Agency awarded a $3,267.81 delivery order to AmerisourceBergen Drug Corp on August 28, 2025, for the supply of Mounjaro 7.5 mg/0.5 mL pens. The contract is a firm fixed price delivery order with an ultimate completion date of August 29, 2025, and will be performed at the contractor's facility in Conshohocken, Pennsylvania. This award was competitively procured with no set-aside designation and represents a child contract under AmerisourceBergen's existing Indefinite...
- The Defense Logistics Agency awarded a delivery order valued at $10,834.81 to AmerisourceBergen Drug Corp for the supply of Mounjaro 7.5 mg/0.5 mL pens on August 5, 2025, with an ultimate completion date of August 6, 2025. This is a firm fixed-price delivery order with no set-aside designation, competitively awarded under the company's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX). AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, serves as a...
- The Defense Logistics Agency awarded a $5,652.64 firm fixed-price delivery order to AmerisourceBergen Drug Corp on September 5, 2025, for the supply of Mounjaro 7.5 mg/0.5 mL pen injectors with an ultimate completion date of September 8, 2025. This non-set-aside contract will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The delivery order represents a child contract action under AmerisourceBergen's substantial Indefinite Delivery Contract with...
- The Defense Logistics Agency awarded a $1,994.92 firm fixed-price delivery order to AmerisourceBergen Drug Corp on July 28, 2025, for the supply of Mounjaro 7.5 mg/0.5 ml pen injectors. This competitive award, with no set-aside designation, is scheduled for completion by July 29, 2025, and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. The delivery order is issued under AmerisourceBergen Drug Corp's larger Indefinite Delivery Contract with DLA...
- SPE2DB20D2001Indefinite Delivery Contract
- SPE2DB20D2001-SPE2DB26FPLHCDelivery Order
The Defense Logistics Agency awarded a $1,632.54 firm fixed price delivery order to AmerisourceBergen Drug Corp on October 16, 2025, for Mounjaro 7.5 mg/0.5 ml pen (0.5 ml), a diabetes medication. The delivery order, which is unset-aside and competitively awarded, is scheduled for completion by October 17, 2025, with performance taking place at the contractor's facility in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 through December 2026, which serves as a comprehensive global pharmaceutical support vehicle for military healthcare programs. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Pennsylvania, is a critical federal vendor supplying an extensive portfolio of medications and medical supplies to Defense Health Agency, U.S. Coast Guard, and other government healthcare systems. The company's federal contract awards demonstrate consistent capability to fulfill diverse pharmaceutical needs through open competition, with delivery orders structured using firm fixed pricing across transactions ranging from small-value orders to substantial procurements. This delivery order for Mounjaro represents routine pharmaceutical supply fulfillment supporting military medical operations worldwide under the DLA's established prime vendor contract framework.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.6k | 10/16/25 |